Jiangsu Hengrui Medicine Co., Ltd.

This early-stage study tested an experimental cancer pill, HRS7415, in 38 adults with advanced solid tumors that had spread. The main goals were to check the drug's safety, find the best dose, and see if it could shrink tumors. Participants took the pill by mouth, and researchers…

This study tested a new medication called HR17031 against a standard insulin (insulin glargine) in 401 Chinese adults with type 2 diabetes whose blood sugar was not well controlled with oral medications. The main goal was to see if HR17031 could lower blood sugar levels (measured…

This study tested a new injectable medicine, HR17031, against a standard insulin (insulin glargine) in 393 adults with type 2 diabetes. Participants had not achieved good blood sugar control despite using basal insulin and metformin. The main goal was to see which treatment bette…

This study tested a new targeted therapy pill (pyrotinib) against a standard chemotherapy drug (docetaxel) in 151 people with advanced non-squamous lung cancer that has a specific HER2 gene mutation. All participants had already tried platinum-based chemo. The main goal was to se…

This study tested a new tablet called HR091506 for adults with gout and high uric acid. It involved 765 participants and compared the new drug to a standard treatment, febuxostat. The main goal was to see if the drug could safely lower uric acid levels below a target at 28 weeks.

This study tested a new drug called HRS-9190 in 70 adults having planned surgery. The drug is a muscle relaxant given to help doctors place a breathing tube more easily during anesthesia. The goal was to see if it works as well as a standard drug and is safe. Results will help de…

This study tested a pain drug called SHR8554 in 20 people—some with kidney problems and some healthy. Researchers wanted to see how the drug moves through the body and if it's safe. The goal was to learn how kidneys affect the drug, not to treat pain directly.

This study checked if a new version of a long-lasting painkiller (bupivacaine liposome injection) behaves the same in the body as the approved version. It involved 36 healthy adults who gave blood samples to measure drug levels. The goal was to confirm the new version is equivale…